George Bakris to Cost-Benefit Analysis
This is a "connection" page, showing publications George Bakris has written about Cost-Benefit Analysis.
Connection Strength
0.108
-
Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective. J Nephrol. 2007 Nov-Dec; 20(6):703-15.
Score: 0.065
-
Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation. Pharmacoeconomics. 2002; 20(1):37-47.
Score: 0.043